Get started
Exact Sciences CorporationExact Sciences CorporationExact Sciences Corporation

Exact Sciences Corporation

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.47 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.53 EUR
Net income (FY)
‪−993.85 M‬ EUR
Revenue (FY)
‪2.67 B‬ EUR
Shares float
‪186.70 M‬
Beta (1Y)
0.25

Employees


Employees (FY)
‪7 K‬
Change (1Y)
+400 +6.06%
Revenue / Employee (1Y)
‪380.72 K‬ EUR
Net income / Employee (1Y)
‪−141.98 K‬ EUR

About Exact Sciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Kevin T. Conroy
Website
exactsciences.com
Headquarters
Madison
Founded
1995
ISIN
US30063P1057
FIGI
BBG01TNXQFV1
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Check out other big names from the same industry as 1EXAS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Highest yielding bonds


EXAS4957195
Exact Sciences Corporation 0.375% 01-MAR-2028
Yield to maturity
—
Maturity date
Mar 1, 2028
EXAS5793007
Exact Sciences Corporation 1.75% 15-APR-2031
Yield to maturity
—
Maturity date
Apr 15, 2031
EXAS5549793
Exact Sciences Corporation 2.0% 01-MAR-2030
Yield to maturity
—
Maturity date
Mar 1, 2030
EXAS4806408
Exact Sciences Corporation 0.375% 15-MAR-2027
Yield to maturity
—
Maturity date
Mar 15, 2027

See all 1EXAS bonds 

ETFs


VTI
Vanguard Total Stock Market ETF
Weight
0.02%
Market value
‪385.59 M‬
USD
VB
Vanguard Small-Cap ETF
Weight
0.18%
Market value
‪288.65 M‬
USD
XBI
State Street SPDR S&P Biotech ETF
Weight
2.78%
Market value
‪213.72 M‬
USD
VBK
Vanguard Small-Cap Growth ETF
Weight
0.40%
Market value
‪162.08 M‬
USD
VXF
Vanguard Extended Market ETF
Weight
0.15%
Market value
‪130.13 M‬
USD
IWR
iShares Russell Midcap ETF
Weight
0.15%
Market value
‪68.86 M‬
USD
FBT
First Trust NYSE Arca Biotechnology Index Fund
Weight
4.95%
Market value
‪67.48 M‬
USD
SCHM
Schwab U.S. Mid-Cap ETF
Weight
0.41%
Market value
‪50.63 M‬
USD
CGGR
Capital Group Growth ETF
Weight
0.26%
Market value
‪48.11 M‬
USD
IWD
iShares Russell 1000 Value ETF
Weight
0.06%
Market value
‪40.33 M‬
USD
VHT
Vanguard Health Care ETF
Weight
0.20%
Market value
‪36.74 M‬
USD

Explore more ETFs 

Sparks


Curated watchlists where 1EXAS is featured.

See all sparks 

Frequently Asked Questions


The current price of 1EXAS is 86.99 EUR — it has increased by 0.21% in the past 24 hours. Watch Exact Sciences Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Exact Sciences Corporation stocks are traded under the ticker 1EXAS.
1EXAS stock has fallen by −0.46% compared to the previous week, the month change is a 44.96% rise, over the last year Exact Sciences Corporation has showed a 120.96% increase.
We've gathered analysts' opinions on Exact Sciences Corporation future price: according to them, 1EXAS price has a max estimate of 90.56 EUR and a min estimate of 64.69 EUR. Watch 1EXAS chart and read a more detailed Exact Sciences Corporation stock forecast: see what analysts think of Exact Sciences Corporation and suggest that you do with its stocks.
1EXAS reached its all-time high on Nov 20, 2025 with the price of 88.45 EUR, and its all-time low was 35.20 EUR and was reached on Aug 11, 2025. View more price dynamics on 1EXAS chart.
See other stocks reaching their highest and lowest prices.
1EXAS stock is 0.21% volatile and has beta coefficient of 0.25. Track Exact Sciences Corporation stock price on the chart and check out the list of the most volatile stocks — is Exact Sciences Corporation there?
Today Exact Sciences Corporation has the market capitalization of ‪16.48 B‬, it has decreased by −0.25% over the last week.
Yes, you can track Exact Sciences Corporation financials in yearly and quarterly reports right on TradingView.
Exact Sciences Corporation is going to release the next earnings report on Feb 24, 2026. Keep track of upcoming events with our Earnings Calendar.
1EXAS earnings for the last quarter are −0.09 EUR per share, whereas the estimation was −0.05 EUR resulting in a −63.35% surprise. The estimated earnings for the next quarter are −0.07 EUR per share. See more details about Exact Sciences Corporation earnings.
Exact Sciences Corporation revenue for the last quarter amounts to ‪725.00 M‬ EUR, despite the estimated figure of ‪690.71 M‬ EUR. In the next quarter, revenue is expected to reach ‪739.68 M‬ EUR.
1EXAS net income for the last quarter is ‪−16.70 M‬ EUR, while the quarter before that showed ‪−1.01 M‬ EUR of net income which accounts for ‪−1.56 K‬% change. Track more Exact Sciences Corporation financial stats to get the full picture.
No, 1EXAS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 8, 2025, the company has ‪7 K‬ employees. See our rating of the largest employees — is Exact Sciences Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Exact Sciences Corporation EBITDA is ‪83.17 M‬ EUR, and current EBITDA margin is 0.84%. See more stats in Exact Sciences Corporation financial statements.
Like other stocks, 1EXAS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Exact Sciences Corporation stock right from TradingView charts — choose your broker and connect to your account.